Stay updated on Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page
- Check3 days agoChange DetectedRevision label updated to v3.5.3, indicating a newer version of the page. This reflects a minor update to the page’s versioning rather than a substantive change to study details.SummaryDifference0.0%

- Check10 days agoChange DetectedThe page’s revision/version label was updated from v3.5.0 to v3.5.2. This does not change the study content displayed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedSite revision label updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedThe update is a minor revision from v3.4.1 to v3.4.2 with no visible user-facing changes to the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded Revision: v3.4.1; removed the funding-lapse notice and Revision: v3.4.0.SummaryDifference0.3%

Stay in the know with updates to Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenvatinib Combo with Pembrolizumab in Solid Tumors Clinical Trial page.